Viewing Study NCT02000050

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2026-02-25 @ 8:31 PM
Study NCT ID: NCT02000050
Status: COMPLETED
Last Update Posted: 2025-01-30
First Post: 2013-11-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rectal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None resectable rectal cancer View
None up-front chemotherapy View
None neo-adjuvant short course radiotherapy View
None short course radiotherapy View